REACT Study

Start date:
Nov 2019

End date:
Dec 2019

Co-ordinated by:
Lumira Dx

Main trial site:
RIE, Edinburgh

A performance evaluation study designed to assess the precision and accuracy of the Lumira DX point of care (POC) and C-Reactive (CRP) assay as an aid in the detection and evaluation of infection, tissue injury and inflammatory disorders.

In the emergency department (ED), CRP is tested in patients presenting with a variety of symptoms as an aid the detection and evaluation of infection, tissue injury or inflammatory disorders.

Primary objective  – To determine the performance of the LumiraDx POC CRP assay when compared to the Siemens Dimension reference method in patients with symptoms of infection, tissue injury and inflammatory disorders.

Sample size –  50 participants over a duration of approximately 4 weeks.